. Prognosis value of immunoregulatory transcripts in patients with TNBC. The overall survival of patients with TNBC were compared in association with the expression of six immunoregulatory transcripts, CTLA-4, IDO1, LAG3, PDCD1, PDL1 and TIM3. TNBC, triple-negative breast cancer; CTLA-4, cytotoxic T-lymphocyte-associated antigen 4; IDO1, indoleamine 2, 3-dioxygenase 1; LAG3, lymphocyte-activation gene 3; PDCD1; PDL1, programmed death-ligand 1; TIM3, T cell immunoglobulin and mucin domain-containing protein 3; HR, hazard ratio.
